Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5203917
Max Phase: Preclinical
Molecular Formula: C44H38F3N7O6S
Molecular Weight: 849.89
Associated Items:
ID: ALA5203917
Max Phase: Preclinical
Molecular Formula: C44H38F3N7O6S
Molecular Weight: 849.89
Associated Items:
Canonical SMILES: Nc1sc(-c2ccc(C(=O)NCCCc3ccc(Nc4ncnc5c4ncn5[C@@H]4O[C@H](CO)[C@@H](O)[C@H]4O)cc3)cc2)c(-c2cccc(C(F)(F)F)c2)c1C(=O)c1ccccc1
Standard InChI: InChI=1S/C44H38F3N7O6S/c45-44(46,47)29-10-4-9-28(20-29)32-33(35(56)25-7-2-1-3-8-25)39(48)61-38(32)26-13-15-27(16-14-26)42(59)49-19-5-6-24-11-17-30(18-12-24)53-40-34-41(51-22-50-40)54(23-52-34)43-37(58)36(57)31(21-55)60-43/h1-4,7-18,20,22-23,31,36-37,43,55,57-58H,5-6,19,21,48H2,(H,49,59)(H,50,51,53)/t31-,36-,37-,43-/m1/s1
Standard InChI Key: FEKYAPNGIDSKCE-PIJZSZHWSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 849.89 | Molecular Weight (Monoisotopic): 849.2556 | AlogP: 6.77 | #Rotatable Bonds: 13 |
Polar Surface Area: 197.74 | Molecular Species: NEUTRAL | HBA: 13 | HBD: 6 |
#RO5 Violations: 4 | HBA (Lipinski): 13 | HBD (Lipinski): 7 | #RO5 Violations (Lipinski): 4 |
CX Acidic pKa: 12.45 | CX Basic pKa: 3.37 | CX LogP: 7.11 | CX LogD: 7.11 |
Aromatic Rings: 7 | Heavy Atoms: 61 | QED Weighted: 0.05 | Np Likeness Score: -0.32 |
1. Awalt JK, Nguyen ATN, Fyfe TJ, Thai BS, White PJ, Christopoulos A, Jörg M, May LT, Scammells PJ.. (2022) Examining the Role of the Linker in Bitopic N6-Substituted Adenosine Derivatives Acting as Biased Adenosine A1 Receptor Agonists., 65 (13.0): [PMID:35729775] [10.1021/acs.jmedchem.2c00320] |
Source(1):